Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAGRAXOFUSP-ERZS: 438 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
438
Total FAERS Reports
114 (26.0%)
Deaths Reported
116
Hospitalizations
438
As Primary/Secondary Suspect
25
Life-Threatening
8
Disabilities
Prescription
Status

FDA Application: 761116 ·

First Report: 20000209 · Latest Report: 20250915

What Are the Most Common TAGRAXOFUSP-ERZS Side Effects?

#1 Most Reported
Capillary leak syndrome
110 reports (25.1%)
#2 Most Reported
Pyrexia
45 reports (10.3%)
#3 Most Reported
Death
36 reports (8.2%)

All TAGRAXOFUSP-ERZS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Capillary leak syndrome 110 25.1% 35 55
Pyrexia 45 10.3% 10 17
Death 36 8.2% 36 3
Disease progression 33 7.5% 16 6
Thrombocytopenia 26 5.9% 7 10
Blood albumin decreased 24 5.5% 2 8
Acute kidney injury 23 5.3% 8 11
Off label use 23 5.3% 12 6
Weight increased 22 5.0% 8 6
Transaminases increased 21 4.8% 6 6
Tumour lysis syndrome 21 4.8% 9 3
Sepsis 19 4.3% 9 14
Liver function test increased 18 4.1% 3 5
Hypoalbuminaemia 17 3.9% 2 7
Hypotension 17 3.9% 7 10
Dyspnoea 15 3.4% 3 9
Hepatic enzyme increased 15 3.4% 0 5
Pneumonia 15 3.4% 5 7
Fatigue 14 3.2% 2 4
Neoplasm recurrence 14 3.2% 9 2

Who Reports TAGRAXOFUSP-ERZS Side Effects? Age & Gender Data

Gender: 22.8% female, 77.2% male. Average age: 65.9 years. Most reports from: US. View detailed demographics →

Is TAGRAXOFUSP-ERZS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2017 1 0 0
2019 42 6 15
2020 46 12 15
2021 32 12 9
2022 24 7 9
2023 31 7 16
2024 24 6 10
2025 6 2 3

View full timeline →

What Is TAGRAXOFUSP-ERZS Used For?

IndicationReports
Blastic plasmacytoid dendritic cell neoplasia 273
Product used for unknown indication 109
Acute myeloid leukaemia 30

TAGRAXOFUSP-ERZS vs Alternatives: Which Is Safer?

TAGRAXOFUSP-ERZS vs TAHOR TAGRAXOFUSP-ERZS vs TALAZOPARIB TAGRAXOFUSP-ERZS vs TALC TAGRAXOFUSP-ERZS vs TALIGLUCERASE ALFA TAGRAXOFUSP-ERZS vs TALIMOGENE LAHERPAREPVEC TAGRAXOFUSP-ERZS vs TALQUETAMAB TAGRAXOFUSP-ERZS vs TALQUETAMAB-TGVS TAGRAXOFUSP-ERZS vs TAMIFLU TAGRAXOFUSP-ERZS vs TAMOXIFEN TAGRAXOFUSP-ERZS vs TAMSULOSIN

Official FDA Label for TAGRAXOFUSP-ERZS

Official prescribing information from the FDA-approved drug label.